Loading: 100%
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 7,500 (as per Q2 2017)no data available
Sector Application Software, TechnologyApplication Software, Technologyno data available
Ticker MDRXno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1710,0011,2512,5013,7515,00
datesClosing price (adj.)
13.10.201713.89
11.10.201713.92
04.10.201714.35
27.09.201714.15
20.09.201713.65
13.09.201713.59
06.09.201713.35
30.08.201713.13
23.08.201712.97
16.08.201713.00
09.08.201712.36
02.08.201711.92
26.07.201712.51
19.07.201711.91
12.07.201712.24
05.07.201712.95
27.06.201712.60
20.06.201712.08
13.06.201712.47
06.06.201712.02
30.05.201711.34
23.05.201711.75
16.05.201712.17
09.05.201712.06
02.05.201712.25
25.04.201711.99
18.04.201711.77
11.04.201712.44
04.04.201712.48
28.03.201712.71
21.03.201712.30
14.03.201711.77
07.03.201711.75
28.02.201712.18
21.02.201712.21
14.02.201712.45
07.02.201711.67
31.01.201711.71
24.01.201711.30
17.01.201711.81
10.01.201711.79
03.01.201710.93
27.12.201610.60
19.12.201610.63
12.12.201610.99
05.12.201610.65
28.11.201611.27
21.11.201610.89
14.11.201610.45
07.11.201610.45
31.10.201612.01
24.10.201612.56
17.10.201613.01
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
13.89n/a
Market Capitalisation
in million USD
2,509n/a
Enterprise Value
in million USD
4,223n/a
Common Shares Outstanding
as per Jul 31, 2017
180,611,892n/a
Preferred Shares Outstanding
as per Jul 31, 2017
n/a
Average Basic Shares Outstanding
TTM
182,840,250n/a
Average Diluted Shares Outstanding
TTM
182,295,250n/a
Index Membership
n/a
Business Summary
Allscripts Healthcare Solutions Inc is a provider of clinical, financial, connectivity and information solutions and related professional services that empower hospitals, physicians and post-acute organizations to deliver world-class outcomes.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 83n/a
Receivables 420n/a
Total Current Assets 623n/a
PP&E 160n/a
Total Assets 3,784n/a
Accounts Payable 115n/a
Current Debt 32n/a
Total Current Liabilities 672n/a
Long-Term Debt 1,314n/a
Total Liabilities 2,209n/a
Total Equity 1,575n/a
Cash Flow
Depreciation & Amortisation 197n/a
Change in Working Capital 29n/a
Operating Cash Flow 246n/a
Net Change in PP&E and Intangibles -44n/a
Investing Cash Flow -276n/a
Dividends Paid 0n/a
Financing Cash Flow 28n/a
Total Change in Cash -2n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 6.15n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 1.61n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.63n/a
Other Ratios
Current Ratio 92.6%n/a
Liabilities to Equity Ratio 140.2%n/a
Debt to Assets Ratio 35.6%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
1,444
1,446
1,373
1,378
1,386
1,550
Sales & Services Revenue
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
Cost of revenue
-1,215
-1,348
-1,677
-1,664
-1,612
-1,758
Cost of Goods & Services
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
Gross Profit
229
98
-304
-286
-225
-208
Other Operating Income
0
0
0
0
0
0
Operating Expenses
-492
-582
-651
-583
-547
-607
Selling, General & Administrative
-388
-384
-420
-359
-339
-393
Selling & Marketing
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
Research & Development
-104
-162
-200
-193
-185
-188
Depreciation & Amortization
0
-36
-31
-31
-23
-26
Provision For Doubtful Accounts
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
Operating Income (Loss)
-263
-484
-955
-869
-772
-814
Non-Operating Income (Loss)
-19
-31
-21
-29
-29
-67
Interest Expense, net
-21
-16
-28
-29
-31
-68
Interest Expense
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
Other Non-Operating Income (Loss)
2
-15
7
1
2
1
Pretax Income (Loss), Adjusted
-282
-515
-975
-897
-802
-881
Abnormal Gains (Losses)
-288
-342
-11
-3
-4
16
Acquired In-Process R&D
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
Pretax Income (Loss)
-570
-857
-987
-900
-805
-865
Income Tax (Expense) Benefit, net
-44
16
44
2
-3
18
Current Income Tax
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-614
-841
-943
-898
-808
-847
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-614
-841
-943
-898
-808
-847
Minority Interest
0
0
0
0
0
0
Net Income
-614
-841
-943
-898
-808
-847
Preferred Dividends
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Net Income Available to Common Shareholders
-614
-841
-943
-898
-808
-847
Remarks
restated on Mar 3, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
158
104
63
53
117
96
Cash & Cash Equivalents
158
104
63
53
117
96
Short Term Investments
0
0
0
0
0
0
Accounts & Notes Receivable
363
302
313
332
328
405
Accounts Receivable, Net
363
302
313
332
328
405
Notes Receivable, Net
0
0
0
0
0
0
Unbilled Revenues
0
0
0
0
0
0
Inventories
0
0
0
0
0
0
Raw Materials
0
0
0
0
0
0
Work In Process
0
0
0
0
0
0
Finished Goods
0
0
0
0
0
0
Other Inventory
0
0
0
0
0
0
Other Short Term Assets
137
167
163
102
94
104
Prepaid Expenses
97
110
108
102
94
103
Derivative & Hedging Assets
0
0
0
0
0
0
Assets Held-for-Sale
0
0
0
0
0
0
Deferred Tax Assets
41
56
55
0
0
0
Income Taxes Receivable
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Miscellaneous Short Term Assets
0
0
0
0
0
1
Total Current Assets
658
573
540
487
538
604
Property, Plant & Equipment, Net
123
155
174
146
126
149
Property, Plant & Equipment
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
Long Term Investments & Receivables
2
2
1
1
0
149
Long Term Investments
0
0
0
0
0
0
Long Term Marketable Securities
0
0
0
0
0
0
Long Term Receivables
0
0
0
0
0
0
Other Long Term Assets
1,722
1,620
1,905
1,830
2,018
2,930
Intangible Assets
588
523
544
490
433
905
Goodwill
1,039
1,039
1,190
1,201
1,223
1,924
Other Intangible Assets
0
0
0
0
0
0
Prepaid Expense
0
0
0
0
0
0
Deferred Tax Assets
5
8
7
2
2
3
Derivative & Hedging Assets
0
0
0
0
0
0
Prepaid Pension Costs
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Investments in Affiliates
0
0
0
0
0
0
Miscellaneous Long Term Assets
89
50
163
138
360
98
Total Noncurrent Assets
1,846
1,777
2,080
1,977
2,144
3,228
Total Assets
2,504
2,350
2,620
2,464
2,682
3,832
Liabilities and owners' equity
Payables & Accruals
163 162663000
183 183098000
250 249651000
201 200853000
184 184423000
277 276570000
Accounts Payable
41 41215000
46 45874000
73 72956000
71 70824000
60 60004000
126 126144000
Accrued Taxes
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
121 121448000
137 137224000
177 176695000
130 130029000
124 124419000
150 150426000
Short Term Debt
45 45477000
79 79305000
16 16350000
27 27498000
13 12609000
27 26735000
Short Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
289 288900000
256 255726000
251 251038000
293 293022000
316 315925000
364 363772000
Deferred Revenue
289 288900000
256 255726000
251 251038000
293 293022000
316 315925000
364 363772000
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
497 497040000
518 518129000
517 517039000
521 521373000
513 512957000
667 667077000
Long Term Debt
323 322664000
363 362697000
545 545133000
539 539193000
613 613022000
1,305 1304648000
Long Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
207 207200000
184 184370000
239 239346000
120 119544000
137 136896000
200 199548000
Accrued Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
19 18891000
20 19750000
29 29080000
23 23168000
20 20273000
18 18009000
Deferred Tax Liabilities
120 119728000
126 125913000
80 79694000
21 21119000
22 22164000
142 141752000
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
69 68581000
39 38707000
131 130572000
75 75257000
94 94459000
40 39787000
Total Noncurrent Liabilities
530 529864000
547 547067000
784 784479000
659 658737000
750 749918000
1,504 1504196000
Total Liabilities
1,027 1026904000
1,065 1065196000
1,302 1301518000
1,180 1180110000
1,263 1262875000
2,171 2171273000
Preferred Equity
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
1,546 1545714000
1,580 1579831000
1,719 1719482000
1,752 1752244000
1,792 1792114000
1,793 1792639000
Common Stock
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
-52 -52075000
-278 -278036000
-278 -278036000
-278 -278036000
-190 -189753000
-311 -310993000
Retained Earnings
-16 -16377000
-18 -17530000
-122 -121556000
-188 -188009000
-190 -190235000
-187 -187351000
Other Equity
-1 -542000
0 76000
-2 -1745000
-2 -1979000
-4 -4242000
-62 -61829000
Equity Before Minority Interest
1,477 1476720000
1,284 1284341000
1,318 1318145000
1,284 1284220000
1,408 1407884000
1,232 1232466000
Minority Interest
0 0
0 0
0 0
0 0
11 11189000
428 428420000
Total Equity
1,477 1476720000
1,284 1284341000
1,318 1318145000
1,284 1284220000
1,419 1419073000
1,661 1660886000
Total Liabilities & Equity
2,504 2503624000
2,350 2349537000
2,620 2619663000
2,464 2464330000
2,682 2681948000
3,832 3832159000
Remarks restated on Mar 12, 2013 n/a restated on Mar 3, 2014 n/a restated on Mar 2, 2015 n/a restated on Feb 29, 2016 n/a restated on Feb 27, 2017 n/a restated on Aug 4, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
74
-1
-104
-66
-2
3
Net Income
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Depreciation & Amortization
132
150
179
174
161
172
Non-Cash Items
69
36
2
46
36
39
Stock-Based Compensation
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
Change in Working Capital
-6
37
4
-50
16
54
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
Cash from Operating Activities
269
223
81
103
212
269
Change in Fixed Assets & Intangibles
-24
-80
-74
-26
-18
-35
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Net Change in Long Term Investment
-13
0
13
-21
-212
-21
Decrease in Long Term Investment
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
Other Investing Activities
-59
-43
-191
-61
-59
-1,097
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
Cash from Investing Activities
-96
-123
-252
-109
-289
-1,154
Dividends Paid
0
0
0
0
0
0
Cash From (Repayment of) Debt
-172
-252
-386
-97
-239
-164
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-16
-220
11
1
104
-121
Increase in Capital Stock
35
6
11
1
104
0
Decrease in Capital Stock
-51
-226
0
0
0
-121
Other Financing Activities
45
317
506
92
278
1,150
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
Cash from Financing Activities
-144
-155
132
-4
142
865
Net Cash Before Disc. Operations and FX
29
-55
-39
-9
65
-20
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
Net Cash Before FX
29
-55
-39
-9
65
-20
Effect of Foreign Exchange Rates
-1
1
-2
0
-1
-1
Net Changes in Cash
28
-54
-41
-10
64
-20
Remarks
restated on Mar 3, 2014 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo